| Name | (5-hydroxy-1H-indol-2-yl)-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl]methanone |
|---|---|
| Synonyms |
Piperazine,1-[(5-hydroxy-1H-indol-2-yl)carbonyl]-4-[3-[(1-methylethyl)amino]-2-pyridinyl]
1-(3-(Isopropylamino)-2-pyridinyl)-4-((5-hydroxyindol-2-yl)carbonyl)piperazine 1-[5-hydroxyindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| Density | 1.323g/cm3 |
|---|---|
| Boiling Point | 674.5ºC at 760 mmHg |
| Molecular Formula | C21H25N5O2 |
| Molecular Weight | 379.45600 |
| Flash Point | 361.7ºC |
| Exact Mass | 379.20100 |
| PSA | 84.49000 |
| LogP | 3.12710 |
| Vapour Pressure | 8.28E-19mmHg at 25°C |
| Index of Refraction | 1.699 |
|
~%
136816-97-2 |
| Literature: The Upjohn Company Patent: US5489593 A1, 1996 ; |
|
~%
136816-97-2 |
| Literature: Romero; Morge; Genin; Biles; Busso; Resnick; Althaus; Reusser; Thomas; Tarpley Journal of Medicinal Chemistry, 1993 , vol. 36, # 10 p. 1505 - 1508 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |